Fundz
Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Basilea partners with BARDA to develop novel antifungals and antibacterials, receives initial funding

Sep 19, 2024•over 1 year ago

Contract Type

agreement

Basel LandschaftBiotechnologyBiopharmaresearch

Description

Basilea Pharmaceutica Ltd has entered into a partnership agreement with the Biomedical Advanced Research and Development Authority (BARDA) to develop urgently needed novel antifungals and antibacterials. Basilea has received an initial funding of USD 29 million from BARDA to support the development of the antifungals fosmanogepix and BAL2062. The agreement includes a potential non-dilutive funding of up to approximately USD 268 million over up to twelve years.

Company Information

Company

Basilea Pharmaceutica Ltd

Location

175 Hegenheimermattweg

Basel Landschaft, Switzerland

About

Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company dedicated to meeting the needs of patients with severe bacterial and fungal infections.

Predictive Intelligence
Strategic

ML-powered predictions for Basilea Pharmaceutica Ltd's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.